Nezallix (Azelastine Hydrochloride, Fluticasone Propionate)

Azelastine Hydrochloride and Fluticasone Propionate, the active ingredients in Nezallix, are a combination antihistamine and corticosteroid presented as a nasal spray for nasal administration. It treats seasonal and perennial allergic rhinitis, relieving nasal congestion, sneezing, and itching in both adults and children.

GNH USA supplies Nezallix as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nezallix is indicated for allergic rhinitis and related nasal inflammation. - Seasonal allergic rhinitis: reduces sneezing, itching, watery discharge, and nasal congestion. - Perennial allergic rhinitis: provides sustained relief of chronic nasal symptoms caused by year‑round allergens. - Nasal congestion due to allergic inflammation: decreases mucosal edema and improves airflow.

Nezallix may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nasal irritation or burning sensation - Bitter or unpleasant taste - Headache - Epistaxis (nosebleed) - Throat irritation or cough

Serious or Rare Side Effects: - Nasal septal perforation - Severe allergic reaction (anaphylaxis) - Vision changes or ocular pressure increase - Systemic corticosteroid effects such as adrenal suppression (rare)

Before using Nezallix, consider the following safety measures. - Pregnancy: consult a healthcare professional before use. - Breastfeeding: discuss potential risks with a physician. - Pediatric use: follow pediatric dosing guidance and monitor for irritation. - Avoid concurrent use of multiple intranasal corticosteroids to limit systemic exposure. - Do not exceed the prescribed frequency of administration. - Store at room temperature: keep in the original container, protect from moisture and direct heat.

Nezallix can interact with other medicines; awareness of interaction severity helps manage risk.

Major Interactions (Avoid): - Concurrent use of additional intranasal corticosteroids may increase systemic steroid effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole) may raise fluticasone levels, risking adrenal suppression.

Moderate Interactions (Monitor Closely): - Oral antihistamines may enhance sedation. - Beta‑blockers can mask signs of anaphylaxis. - Ritonavir or other potent CYP3A4 modulators may modestly increase fluticasone exposure. - Nasal decongestants used together may increase local irritation.